QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Acetazolamide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 30,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiseizure |
| Classification: | Drug Assays |
Acetylsalicyclic acid Dipyridamole Salicyclic Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 500 ng/mL 20 – 4,000 ng/mL 40 – 4,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Acetylsalicylic Acid and Salicylic acid in presence of Rosuvastatin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 2,500 ng/mL 40 – 20,000 ng/mL |
| Sample Volume: | 0.4 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Acetylsalicylic Acid in presence of Dipyridamole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 750 ng/mL |
| Sample Volume: | 0.4 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Acetylsalicylic AcidSalicylic Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 2,500 ng/mL50 – 10,000 ng/mL |
| Sample Volume: | 0.4 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Acetylsalicylic AcidSalicylic Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 2,500 ng/mL 500 – 7,000 ng/mL |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Acetylsalicylic AcidSalicylic Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 100 – 10,000 ng/mL 500 – 40,000 ng/mL |
| Sample Volume: | 0.20 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Acetylsalicylic AcidSalicylic Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 10,000 ng/mL |
| Sample Volume: | 0.03 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Acyclovir (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 5,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antiviral – HSV |
| Classification: | Drug Assays |
Adalimumab (ADA) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.01 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | MSD |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
Adalimumab (Nab) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.150 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | Cell-Based |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
Adalimumab (PK) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 250 – 10,000 ng/mL |
| Sample Volume: | 0.01 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
Adiponectin (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 5 – 250 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Adiponectin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 250 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Adiponectin (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 780 – 100,000 ng/mL |
| Sample Volume: | 0.04 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Adrenocorticotropic Hormone (ACTH) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 6.40 – 528 pg/mL |
| Sample Volume: | 0.4 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Agomelatine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 250 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Agomelatine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 15000 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Albendazole Albendazole Sulfoxide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 250 ng/mL 5 – 2,500 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anthelmintic |
| Classification: | Drug Assays |
Albumin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 15 – 600 mg/L |
| Sample Volume: | 0.01 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | Nephelometry |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Albumin (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 2.50 – 90.0 mg/L |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | Nephelometry |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Albuterol (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.25 – 25 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
Albuterol (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 1,000 pg/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
ALDH2 (rs671) Genotyping (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | TaqMan; QuantStudio |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Genomic Biomarkers |
Alendronate (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 1.00 – 1,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Bone Health |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
